Medical Bulletin 15/ October/ 2024 Dr. Bhumika Maikhuri15 Oct 2024 3:00 PM ISTHere are the top medical news for the day:1 in 4 Adults Suspect They Have Undiagnosed ADHDA new national survey of 1,000 American adults commissioned...
Study Identifies Signs Tied to More Severe Cases of RSV Dr. Bhumika Maikhuri15 Oct 2024 8:15 AM ISTRespiratory syncytial virus (RSV) is the leading cause of hospitalization in young children due to respiratory complications such as bronchiolitis and...
Medical Bulletin 07/ October/ 2024 Dr. Bhumika Maikhuri7 Oct 2024 3:00 PM ISTHere are the top medical news for the day:Want to Prevent Back Pain? Reduce Sitting TimeA new study from the University of Turku in Finland showed...
WHO recommends maternal vaccine and antibody shot for preventing RSV in infants Dr. Bhumika Maikhuri7 Oct 2024 8:45 AM ISTThe World Health Organization recommended vaccinating pregnant women and administering infants with an antibody to prevent severe respiratory synctial...
Moderna lays out plan to slice research and development spending MD Bureau Team15 Sept 2024 10:45 AM ISTWashington: Shares of Moderna tumbled after the vaccine developer said it was cutting research and development spending and pushed back its time...
Understanding RSV Infection in Children: Symptoms, Diagnosis and Prevention - Dr Srinivas Jakka Dr Srinivas Jakka6 March 2024 3:38 PM IST Introduction Respiratory syncytial virus, or RSV, is one of the most common viruses causing respiratory infection across the world. Many...
AstraZeneca to acquire vaccine developer Icosavax for up to USD 1.1 billion Ruchika Sharma12 Dec 2023 3:30 PM ISTCambridge: AstraZeneca has entered into a definitive agreement to acquire Icosavax, Inc., a US-based clinical-stage biopharmaceutical company...
RSV infection during infancy tied to onset of asthma in childhood: Lancet Aditi31 July 2023 8:00 PM ISTA study published in The Lancet has found an age-dependent association between respiratory syncytial virus or RSV infection during infancy and...
Sanofi-AstraZeneca Beyfortus gets USFDA nod for protection of infants against RSV disease Ruchika Sharma18 July 2023 11:24 AM ISTParis: The U.S. Food and Drug Administration (FDA) has approved Sanofi and AstraZeneca’s Beyfortus (nirsevimab-alip) for the prevention of...
Nirsevimab delivers 83 percent reduction in RSV infant hospitalizations in a real world clinical trial setting: Sanofi Ruchika Sharma14 May 2023 2:00 PM ISTRSV is the most common cause of LRTD, including bronchiolitis and pneumonia, in infants.
Nose swabs may predict longer intensive care among babies suffering from RSV bronchiolitis Dr. Kamal Kant Kohli31 Dec 2022 11:00 AM ISTWhen a child with RSV requires intensive care, parents often ask about how long it will take before their child can go home. Currently, there is no...
Atypical Bacterial Pneumonia in Children: IAP Guidelines Ayesha Sadaf24 Sept 2022 10:00 AM ISTCommunity-acquired pneumonia (CAP) or infection of the lungs is a common cause of morbidity and mortality in children. In India, the typical...
